Download Folie 1 - Springer Static Content Server

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Intraocular Lymphoma
Manfred Zierhut
Centre of Ophthalmology
University of Tuebingen,
Germany
Ocular History
 46 year old woman
 3-2000: OD blurred vision
 1999: OS „similar problems“
April 2000: First Presentation
 VA: OD 20/20, OS 20/25
 Mild AC cell infiltration
 Fundus:
 Multifocal chorioretinitis
 Pigment atrophy
April 2000: First Presentation
 ESR: 59/100 (known since 1995)
 Prednisolone 75 mg
 Improvement
June 2000 to February 2001
 6-2000: Recurrence with retinal infiltration
 8-2000:
 OD: CME: VA 20/32
 Prednisolone: minimal improvement
 9-2000: Optic disc edema with bleeding
 11-2000: Azathioprine 150 mg
 2-2001: inactive, VA 20/20
May 2001
 Peripheral CNV with
subretinal bleeding
 Serpiginous chorioretinitis?
July 2001 to August 2001
 7-2001:
 Pigmentepithel detachment
 Exsudative retinal detachment
 MRI of the brain: negative
 Steroid induced diabetes
 8-2001:
 Cyclosporine A: bleeding in resorption
September to October 2001
 9-2001:
 OD: 20/100, OS: 20/32
 Massive vitreous cells
 10-2001:
 OD: 20/400
 Diagnostic ppV: no lymphoma cells
Diagnosis after choroidal Biopsy
 B-cell non-Hodgkin lymphoma
 Positive for CD20, MIB1
 Negative for CD3, CD138, c-kit,
HMB45, κ-, and λ
 Bone marrow: negative
Problems





Ocular disease with the highest 5-year letality
Increasing incidence
Diagnosis often late
Negative vitreous biopsy does not exclude NHL
Therapy not clear when CNS-manifestation is
missing
Case Report:
Treatment
 Intravenous Methotrexate
 10-2001: 1. course (7.52 g)
 11-2001: 2. and 3. course
 12-2001: 4. and 5. course
 1-2002: 6. course
Follow-up
 11-2001:
 VA: 20/200, 20/40
 Remaining bleedings
 Resorption of the infiltration
 Scarring
 10-2007:
 No signs of recurrence or scarring
 VA: 20/200, 20/20
Final Diagnosis
 Non-Hodgkin lymphoma without CNS
involvement
 Untypical clinical manifestation immitating
 Serpigninous
 Multifocal chorioretinitis
 With development of subretinal
neovascularisation membrane
 Good response of the eye to i.v. MTX
Conclusion
 Clinic of intraocular lymphoma highly variable
 Can mimic multiple other uveitis disorders
 When diagnostic ppV negative but still suggestive
for lymphoma: retinal biopsy
 In this patient i.v. MTX (3 g/m2) was effective as
monotherapy
Related documents